Literature DB >> 8706033

Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice.

A H Reitmair1, M Redston, J C Cai, T C Chuang, M Bjerknes, H Cheng, K Hay, S Gallinger, B Bapat, T W Mak.   

Abstract

Hereditary nonpolyposis colorectal cancer is associated with defects in DNA mismatch repair. Here, we characterize tumor susceptibility of the recently described Msh2-deficient mouse model. Within the first year of observation, all homozygous mice succumbed to disease, with lymphomas observed in at least 80% of the cases. The majority (70%) of animals 6 months or older developed intestinal neoplasms associated with APC inactivation. Microsatellite instability was more common in carcinomas than in adenomas, but uncommon in normal tissues. Some animals (7%) developed a variety of skin neoplasms analogous to the Muir-Torre syndrome. Msh2-/- mice implicate a direct role for mismatch repair in several neoplasms with striking phenotypic similarities to humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706033

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

Review 1.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

2.  Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations.

Authors:  A Abuin; H Zhang; A Bradley
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 3.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

4.  A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer.

Authors:  Alexander M Betzler; Susan Kochall; Linda Blickensdörfer; Sebastian A Garcia; May-Linn Thepkaysone; Lahiri K Nanduri; Michael H Muders; Jürgen Weitz; Christoph Reissfelder; Sebastian Schölch
Journal:  J Vis Exp       Date:  2017-07-06       Impact factor: 1.355

5.  The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1.

Authors:  A Bhandari; W Gordon; D Dizon; A S Hopkin; E Gordon; Z Yu; B Andersen
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

6.  Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.

Authors:  Laura Thomas; Lan Kluwe; Nadia Chuzhanova; Victor Mautner; Meena Upadhyaya
Journal:  Neurogenetics       Date:  2010-04-01       Impact factor: 2.660

Review 7.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

Review 8.  Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations.

Authors:  Prathap Bandipalliam
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

9.  Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.

Authors:  S E Andrew; M McKinnon; B S Cheng; A Francis; J Penney; A H Reitmair; T W Mak; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

10.  Sebaceous neoplasia and Torre-Muir syndrome.

Authors:  A J F Lazar; S Lyle; E Calonje
Journal:  Curr Diagn Pathol       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.